Saturday, November 23, 2024
HomeTagsPlasma neurofilament light chain

plasma neurofilament light chain

FDA approves QALSODY as the first treatment targeting a genetic cause of ALS

Ionis Pharmaceuticals, Inc. announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY 100 mg/15mL injection for the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics